Evidence map›Paper›PMID 25055272›Full record

ArticleAJR. American journal of roentgenology2014

MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis.

Chung Y Kong, Lesley Meng, Zehra B Omer, J Shannon Swan, Serene Srouji, G Scott Gazelle, Fiona M Fennessy

Abstract read
In one paragraph

Article in AJR. American journal of roentgenology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Abnormal uterine bleeding successfully treatedWorld journal of clinical cases · 2024
    Article
  5. Article
  6. Role of magnetic resonance-high intensity focused ultrasound (MR-HIFU) in uterine fibroids management: an updated systematic review and meta-analysis.Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017
    Article
  12. Treatment of Movement Disorders With Focused Ultrasound.Journal of central nervous system disease · 2017
    Review
  13. Review
  14. Review
  15. Review
  16. Emerging non-cancer applications of therapeutic ultrasound.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2015
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Chung Y Kong1 Department of Radiology, Massachusetts General Hospital, Institute for Technology Assessment, 101 Merrimac St, 10th Fl, Boston, MA 02114.
Lesley Meng
Zehra B Omer
J Shannon Swan
Serene Srouji
G Scott Gazelle
Fiona M Fennessy
Harvard University · USBrigham and Women's Hospital · US

Funding

Applications of Multi-Criteria Optimization (AMCO) to Cancer Simulation ModelingK25CA133141 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI KONG, CHUNG YIN · 2009 to 2013
$844k
NCI NIH HHS K25 CA133141NCI NIH HHS K25-CA133141
6 · The paper itself

Abstract

OBJECTIVE. The purpose of this article is to evaluate the cost effectiveness of a treatment strategy for symptomatic uterine fibroids that uses MRI-guided focused ultrasound as a first-line therapy relative to uterine artery embolization (UAE) or hysterectomy. MATERIALS AND METHODS. We developed a decision-analytic model to compare the cost effectiveness of three first-line treatment strategies: MRI-guided focused ultrasound, UAE, and hysterectomy. Treatment-specific short- and long-term utilities, lifetime costs, and quality-adjusted life years (QALYs) were incorporated, allowing us to conduct an incremental cost-effectiveness analysis, using a societal willingness-to-pay (WTP) threshold of $50,000/QALY to designate a strategy as cost effective. Sensitivity analyses were subsequently performed on all key parameters. RESULTS. In the base-case analysis, UAE as a first-line treatment of symptomatic fibroids was the most effective and expensive strategy (22.75 QALYs; $22,968), followed by MRI-guided focused ultrasound (22.73 QALYs; $20,252) and hysterectomy (22.54 QALYs; $11,253). MRI-guided focused ultrasound was cost effective relative to hysterectomy, with an associated incremental cost-effectiveness ratio (ICER) of $47,891/QALY. The ICER of UAE relative to MRI-guided focused ultrasound was $234,565/QALY, exceeding the WTP threshold of $50,000/QALY, therefore rendering MRI-guided focused ultrasound also cost effective relative to UAE. In sensitivity analyses, results were robust to changes in most parameters but were sensitive to changes in probabilities of recurrence, symptom relief, and quality-of-life measures. CONCLUSION. First-line treatment of eligible women with MRI-guided focused ultra-sound is a cost-effective noninvasive strategy. For those not eligible for MRI-guided focused ultra-sound, UAE remains a cost-effective option. These recommendations integrate both the short- and long-term decrements in quality of life associated with the specific treatment modalities.

Indexed as

AdultCost-Benefit AnalysisEfficiency, OrganizationalFemaleHumansHysterectomyLeiomyomaMagnetic Resonance Imaging, InterventionalModels, EconomicQuality-Adjusted Life YearsUltrasonic TherapyUterine Neoplasmscost effectivenesshysterectomyMRI-guided focused ultrasounduterine fibroids

Identifiers

PMID25055272
PMCPMC4321860
OpenAlexW2042091518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.